Luca Neri

Prof. Luca Neri

Department of Morphology, Surgery and Experimental Medicine, School of Medicine, University of Ferrara, 35-44121 Ferrara, Italy
orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2018 in Oncotarget
Verified
Journal Article
Open access
PDF file
CSCarolina Simioni
Carolina Simioni
GZGiorgio Zauli
Giorgio Zauli
AMAlberto M. Martelli
Alberto M. Martelli
MVMarco Vitale
Marco Vitale
GSGianni Sacchetti
Gianni Sacchetti
LNLuca Neri
Luca Neri
Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging

16 July 1992 in Nature
Verified
Journal Article
Closed access
PDF file
AMAlberto M. Martelli
Alberto M. Martelli
RGR. Stewart Gilmour
R. Stewart Gilmour
VBValeria Bertagnolo
Valeria Bertagnolo
LNLuca Neri
Luca Neri
LMLucia Manzoli
Lucia Manzoli
LCLucio Cocco
Lucio Cocco

1 October 2002 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
LNLuca Neri
Luca Neri
PBPaola Borgatti
Paola Borgatti
SCSilvano Capitani
Silvano Capitani
AMAlberto M Martelli
Alberto M Martelli

29 July 2013 in Leukemia
Verified
Journal Article
Open access
PDF file
LNLuca Neri
Luca Neri
ACAlice Cani
Alice Cani
AMA M Martelli
A M Martelli
CSCarolina Simioni
Carolina Simioni
CJC Junghanss
C Junghanss
SCS Capitani
S Capitani
B-precursor acute lymphoblastic leukemia (B-pre ALL) is a malignant disorder characterized by the abnormal proliferation of B-cell progenitors. The prognosis of B-pre ALL has improved in pediatric patients, but the outcome is much less successful in adults. Constitutive activation of the phosphatidylinositol 3-kinase (PI3K), Akt and the mammalian target of rapamycin (mTOR) (PI3K/Akt/mTOR) network is a feature of B-pre ALL, where it strongly influences cell growth and survival. RAD001, a selective mTORC1 inhibitor, has been shown to be cytotoxic against many types of cancer including hematological malignancies. To investigate whether mTORC1 could represent a target in the therapy of B-pre ALL, we treated cell lines and adult patient primary cells with RAD001. We documented that RAD001 decreased cell viability, induced cell cycle arrest in G0/G1 phase and caused apoptosis in B-pre ALL cell lines. Autophagy was also induced, which was important for the RAD001 cytotoxic effect, as downregulation of Beclin-1 reduced drug cytotoxicity. RAD001 strongly synergized with the novel allosteric Akt inhibitor MK-2206 in both cell lines and patient samples. Similar results were obtained with the combination CCI-779 plus GSK 690693. These findings point out that mTORC1 inhibitors, either as a single agent or in combination with Akt inhibitors, could represent a potential therapeutic innovative strategy in B-pre ALL.

8 February 2018 in Oncotarget
Verified
Journal Article
Open access
MFMartina Ferioli
Martina Ferioli
GZGiorgio Zauli
Giorgio Zauli
AMAlberto M. Martelli
Alberto M. Martelli
MVMarco Vitale
Marco Vitale
JMJames A. McCubrey
James A. McCubrey
LNLuca Neri
Luca Neri
Impact of physical exercise in cancer survivors during and after antineoplastic treatments Impact of physical exercise in cancer survivors during and after antineoplastic treatments

14 July 2000 in FEBS Letters
Verified
Journal Article
Closed access
PBPaola Borgatti
Paola Borgatti
AMAlberto M Martelli
Alberto M Martelli
ABAlfonso Bellacosa
Alfonso Bellacosa
RCRiccardo Casto
Riccardo Casto
LMLeo Massari
Leo Massari
LNLuca Neri
Luca Neri